The G-NASH model with an AUC of 82.9% for identifying NASH patients with normal ALT, whereas the serum Golgi protein 73 incorporated in this model is unfeasible in the clinic (35). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.